Belimumab powder for concentrate for solution for infusion

GLAXOSMITHKLINE (IRELAND) LIMITED🇨🇳 National Medical Products Administration

Approval Id: 7ucizL9nB5u
Approval Number: S20190033
Generic Name: 注射用贝利尤单抗
Generic Name En: Belimumab powder for concentrate for solution for infusion
Trade Name: 倍力腾
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 400mg/瓶
Reg Date: 2019-12-10
Expired Date: 2024-07-11
Company Name: GLAXOSMITHKLINE (IRELAND) LIMITED
Company Address: 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
Production Company Name: glaxosmithkline manufacturing s.p.a.
Production Company Address: Strada Provinciale Asolana no. 90, San Polo di Torrile, Parma 43056, Italy
Company Detail Path: /organization/glaxosmithkline-ireland-limited

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 10, 2019

Approval ID

7ucizL9nB5u

Type

生物制品